EONS 2019 | The HPV vaccine for preventing cervical and oropharyngeal cancer

Daniel Kelly

Daniel Kelly, FRCN, RN, PhD, FRSA, Cardiff University, Cardiff, UK, stresses the importance of ensuring patient safety, with a focus on the human papillomavirus (HPV) vaccination to prevent cervical and oropharyngeal cancers, and how appropriate allocation of resources can help maintain patient safety. This interview took place at EONS 12 during the European Society for Medical Oncology (ESMO) 2019 congress in Barcelona, Spain.

Share this video